Download in English|Deutsch|Français | Español

GARDP was able to make remarkable progress in 2020 despite the challenges of the COVID-19 pandemic. The Activity Report 2020 Executive Summary provides an overview of the work of GARDP to develop and make accessible treatments for the drug-resistant infections posing the greatest threat to health.

A flipbook version of the Executive Summary is available to view below: